BioLineRx Ltd. (SEC Filing Page | XBRL Cloud Viewer | XBRL Instance)

Line Label Object Class Period Type Balance Report ElementName
1 00000001 - Document - Document and Entity Information Network

*

*

 http://biolinerx.com/role/DocumentAndEntityInformation
2 Implied Table Table

*

*

 implied:Table
3 Document And Entity Information Abstract blrx:DocumentAndEntityInformationAbstract
4 Entity Registrant Name Concept (Text/String) For Period dei:EntityRegistrantName
5 Entity Central Index Key Concept (CIK Number) For Period dei:EntityCentralIndexKey
6 Document Type Concept (Submission Type) For Period dei:DocumentType
7 Document Period End Date Concept (Date) For Period dei:DocumentPeriodEndDate
8 Amendment Flag Concept (Yes/No) For Period dei:AmendmentFlag
9 Current Fiscal Year End Date Concept (Month/Day) For Period dei:CurrentFiscalYearEndDate
10 Is Entity a Well-known Seasoned Issuer? Concept (Yes/No) For Period dei:EntityWellKnownSeasonedIssuer
11 Is Entity a Voluntary Filer? Concept (Yes/No) For Period dei:EntityVoluntaryFilers
12 Is Entity's Reporting Status Current? Concept (Yes/No) For Period dei:EntityCurrentReportingStatus
13 Entity Filer Category Concept (Filer Category) For Period dei:EntityFilerCategory
14 Entity Shell Company Concept (Yes/No) For Period dei:EntityShellCompany
15 Entity Emerging Growth Company Concept (Yes/No) For Period dei:EntityEmergingGrowthCompany
16 Entity Public Float Concept (Monetary) As Of Credit dei:EntityPublicFloat
17 Entity Common Stock, Shares Outstanding Concept (Shares) As Of dei:EntityCommonStockSharesOutstanding
18 Document Fiscal Period Focus Concept (Fiscal Period) For Period dei:DocumentFiscalPeriodFocus
19 Document Fiscal Year Focus Concept (Year) For Period dei:DocumentFiscalYearFocus
20 00000002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Network

*

*

 http://biolinerx.com/role/ConsolidatedStatementsOfFinancialPosition
21 Implied Table Table

*

*

 implied:Table
22 Statement of financial position [abstract] Abstract ifrs-full:StatementOfFinancialPositionAbstract
23 Assets Abstract ifrs-full:AssetsAbstract
24 CURRENT ASSETS Abstract ifrs-full:CurrentAssetsAbstract
25 Cash and cash equivalents Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
26 Short-term bank deposits Concept (Monetary) As Of Debit ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
27 Prepaid expenses Concept (Monetary) As Of Debit ifrs-full:CurrentPrepaidExpenses
28 Other receivables Concept (Monetary) As Of Debit ifrs-full:OtherCurrentReceivables
29 Total current assets Concept (Monetary) As Of Debit ifrs-full:CurrentAssets
30 NON-CURRENT ASSETS Abstract ifrs-full:NoncurrentAssetsAbstract
31 Long-term prepaid expenses Concept (Monetary) As Of Debit ifrs-full:NoncurrentPrepayments
32 Long-term investment Concept (Monetary) As Of Debit ifrs-full:LongtermDeposits
33 Property and equipment, net Concept (Monetary) As Of Debit ifrs-full:PropertyPlantAndEquipment
34 Intangible assets, net Concept (Monetary) As Of Debit ifrs-full:IntangibleAssetsOtherThanGoodwill
35 Total non-current assets Concept (Monetary) As Of Debit ifrs-full:NoncurrentAssets
36 Total assets Concept (Monetary) As Of Debit ifrs-full:Assets
37 Liabilities and equity Abstract ifrs-full:EquityAndLiabilitiesAbstract
38 CURRENT LIABILITIES Abstract ifrs-full:CurrentLiabilitiesAbstract
39 Current maturities of long-term loans Concept (Monetary) As Of Credit ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
40 Accounts payable and accruals: Abstract ifrs-full:TradeAndOtherCurrentPayablesAbstract
41 Trade Concept (Monetary) As Of Credit ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
42 Other Concept (Monetary) As Of Credit ifrs-full:OtherCurrentPayables
43 Total current liabilities Concept (Monetary) As Of Credit ifrs-full:CurrentLiabilities
44 NON-CURRENT LIABILITIES Abstract ifrs-full:NoncurrentLiabilitiesAbstract
45 Long-term loans, net of current maturities Concept (Monetary) As Of Credit ifrs-full:NoncurrentPortionOfNoncurrentLoansReceived
46 Warrants Concept (Monetary) As Of Credit blrx:Warrants
47 Total non-current liabilities Concept (Monetary) As Of Credit ifrs-full:NoncurrentLiabilities
48 COMMITMENTS AND CONTINGENT LIABILITIES Concept (Monetary) As Of Credit blrx:CommitmentsAndContingentLiabilities
49 Total liabilities Concept (Monetary) As Of Credit ifrs-full:Liabilities
50 EQUITY Abstract ifrs-full:EquityAbstract
51 Ordinary shares Concept (Monetary) As Of Credit ifrs-full:IssuedCapital
52 Share premium Concept (Monetary) As Of Credit ifrs-full:SharePremium
53 Capital reserve Concept (Monetary) As Of Credit ifrs-full:CapitalReserve
54 Other comprehensive loss Concept (Monetary) As Of Credit ifrs-full:AccumulatedOtherComprehensiveIncome
55 Accumulated deficit Concept (Monetary) As Of Credit ifrs-full:RetainedEarnings
56 Total equity Concept (Monetary) As Of Credit ifrs-full:Equity
57 Total liabilities and equity Concept (Monetary) As Of Credit ifrs-full:EquityAndLiabilities
58 00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Network

*

*

 http://biolinerx.com/role/ConsolidatedStatementsOfComprehensiveLoss
59 Implied Table Table

*

*

 implied:Table
60 Profit or loss [abstract] Abstract ifrs-full:IncomeStatementAbstract
61 RESEARCH AND DEVELOPMENT EXPENSES Concept (Monetary) For Period Debit ifrs-full:ResearchAndDevelopmentExpense
62 SALES AND MARKETING EXPENSES Concept (Monetary) For Period Debit ifrs-full:SalesAndMarketingExpense
63 GENERAL AND ADMINISTRATIVE EXPENSES Concept (Monetary) For Period Debit ifrs-full:SellingGeneralAndAdministrativeExpense
64 OPERATING LOSS Concept (Monetary) For Period Credit ifrs-full:ProfitLossFromOperatingActivities
65 NON-OPERATING INCOME (EXPENSES), NET Concept (Monetary) For Period Credit blrx:ProfitLossFromNonOperatingActivities
66 FINANCIAL INCOME Concept (Monetary) For Period Credit ifrs-full:FinanceIncome
67 FINANCIAL EXPENSES Concept (Monetary) For Period Debit ifrs-full:FinanceCosts
68 NET LOSS AND COMPREHENSIVE LOSS Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
69 LOSS PER ORDINARY SHARE - BASIC AND DILUTED Concept (Share) For Period ifrs-full:BasicAndDilutedEarningsLossPerShare
70 WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATION OF LOSS PER ORDINARY SHARE Concept (Shares) For Period ifrs-full:WeightedAverageShares
71 00000004 - Statement - STATEMENTS OF CHANGES IN EQUITY Network

*

*

 http://biolinerx.com/role/StatementsOfChangesInEquity
72 Statement of changes in equity [table] Table

*

*

 ifrs-full:StatementOfChangesInEquityTable
73 Components of equity [axis] Axis ifrs-full:ComponentsOfEquityAxis
74 Equity [member] Member ifrs-full:EquityMember
75 Ordinary shares [Member] Member ifrs-full:IssuedCapitalMember
76 Share premium [Member] Member ifrs-full:SharePremiumMember
77 Capital reserves [Member] Member ifrs-full:CapitalReserveMember
78 Other comprehensive loss [Member] Member blrx:OtherComprehensiveIncomeLossMember
79 Accumulated deficit [Member] Member ifrs-full:RetainedEarningsMember
80 Statement of changes in equity [line items] LineItems ifrs-full:StatementOfChangesInEquityLineItems
81 BALANCE Concept (Monetary) As Of Credit ifrs-full:Equity
82 CHANGES IN Abstract ifrs-full:ChangesInEquityAbstract
83 Issuance of share capital, net Concept (Monetary) For Period Credit ifrs-full:IssueOfEquity
84 Employee stock options exercised Concept (Monetary) For Period Credit ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
85 Employee stock options expired Concept (Monetary) For Period Credit blrx:IncreaseDecreaseThroughExpiredOfOptions
86 Share-based compensation Concept (Monetary) For Period Credit ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
87 Other comprehensive loss Concept (Monetary) For Period Credit ifrs-full:OtherComprehensiveIncome
88 Comprehensive loss for the year Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
89 BALANCE Concept (Monetary) As Of Credit ifrs-full:Equity
90 00000006 - Disclosure - GENERAL INFORMATION Network

*

*

 http://biolinerx.com/role/GeneralInformation
91 Implied Table Table

*

*

 implied:Table
92 Disclosure of general information [Abstract] Abstract blrx:DisclosureOfGeneralInformationAbstract
93 GENERAL INFORMATION Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory
94 00000007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Network

*

*

 http://biolinerx.com/role/SignificantAccountingPolicies
95 Implied Table Table

*

*

 implied:Table
96 Disclosure of significant accounting policies [Abstract] Abstract blrx:DisclosureOfSignificantAccountingPoliciesAbstract
97 SIGNIFICANT ACCOUNTING POLICIES Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
98 00000008 - Disclosure - FINANCIAL RISK MANAGEMENT Network

*

*

 http://biolinerx.com/role/FinancialRiskManagement
99 Implied Table Table

*

*

 implied:Table
100 Disclosure of detailed information about financial instruments [abstract] Abstract ifrs-full:DisclosureOfFinancialInstrumentsAbstract
101 FINANCIAL RISK MANAGEMENT Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfFinancialInstrumentsExplanatory
102 00000009 - Disclosure - CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS Network

*

*

 http://biolinerx.com/role/CriticalAccountingEstimatesAndJudgments
103 Implied Table Table

*

*

 implied:Table
104 Disclosure of critical accounting estimates and judgments [Abstract] Abstract blrx:DisclosureOfAccountingJudgementsAndEstimatesExplanatoryAbstract
105 CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory
106 00000010 - Disclosure - CASH AND CASH EQUIVALENTS Network

*

*

 http://biolinerx.com/role/CashAndCashEquivalents
107 Implied Table Table

*

*

 implied:Table
108 Cash and cash equivalents [abstract] Abstract ifrs-full:CashAndCashEquivalentsAbstract
109 CASH AND CASH EQUIVALENTS Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory
110 00000011 - Disclosure - SHORT-TERM BANK DEPOSITS Network

*

*

 http://biolinerx.com/role/Short-termBankDeposits
111 Implied Table Table

*

*

 implied:Table
112 Disclosure of short-term bank deposits [Abstract] Abstract blrx:DisclosureOfShorttermBankDepositsAbstract
113 SHORT-TERM BANK DEPOSITS Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDepositsFromBanksExplanatory
114 00000012 - Disclosure - LONG-TERM INVESTMENT Network

*

*

 http://biolinerx.com/role/Long-termInvestment
115 Implied Table Table

*

*

 implied:Table
116 Disclosure of Long-term investment [Abstract] Abstract blrx:DisclosureOfLongTermInvestmentAbstract
117 LONG-TERM INVESTMENT Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfInvestmentPropertyExplanatory
118 00000013 - Disclosure - PROPERTY AND EQUIPMENT Network

*

*

 http://biolinerx.com/role/PropertyAndEquipment
119 Implied Table Table

*

*

 implied:Table
120 Disclosure of detailed information about property, plant and equipment [abstract] Abstract ifrs-full:DisclosureOfPropertyPlantAndEquipmentAbstract
121 PROPERTY AND EQUIPMENT Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
122 00000014 - Disclosure - INTANGIBLE ASSETS Network

*

*

 http://biolinerx.com/role/IntangibleAssets
123 Implied Table Table

*

*

 implied:Table
124 Disclosure of detailed information about intangible assets [abstract] Abstract ifrs-full:DisclosureOfIntangibleAssetsAbstract
125 INTANGIBLE ASSETS Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfIntangibleAssetsExplanatory
126 00000015 - Disclosure - LONG-TERM LOANS Network

*

*

 http://biolinerx.com/role/Long-termLoans
127 Implied Table Table

*

*

 implied:Table
128 Disclosure of detailed information about borrowings [abstract] Abstract ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsAbstract
129 LONG-TERM LOANS Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfBorrowingsExplanatory
130 00000016 - Disclosure - EQUITY Network

*

*

 http://biolinerx.com/role/Equity
131 Implied Table Table

*

*

 implied:Table
132 Disclosure of classes of share capital [abstract] Abstract ifrs-full:DisclosureOfClassesOfShareCapitalAbstract
133 EQUITY Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
134 00000017 - Disclosure - TAXES ON INCOME Network

*

*

 http://biolinerx.com/role/TaxesOnIncome
135 Implied Table Table

*

*

 implied:Table
136 Disclosure of taxes on income [Abstract] Abstract blrx:DisclosureOfIncomeTaxesAbstract
137 TAXES ON INCOME Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfIncomeTaxExplanatory
138 00000018 - Disclosure - LOSS PER SHARE Network

*

*

 http://biolinerx.com/role/LossPerShare
139 Implied Table Table

*

*

 implied:Table
140 Earnings per share [abstract] Abstract ifrs-full:EarningsPerShareAbstract
141 LOSS PER SHARE Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfEarningsPerShareExplanatory
142 00000019 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES Network

*

*

 http://biolinerx.com/role/CommitmentsAndContingentLiabilities
143 Implied Table Table

*

*

 implied:Table
144 Disclosure of commitments and contingent liabilities [Abstract] Abstract blrx:DisclosureOfCommitmentsAndContingentLiabilitiesAbstract
145 COMMITMENTS AND CONTINGENT LIABILITIES Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory
146 00000020 - Disclosure - TRANSACTIONS AND BALANCES WITH RELATED PARTIES Network

*

*

 http://biolinerx.com/role/TransactionsAndBalancesWithRelatedParties
147 Implied Table Table

*

*

 implied:Table
148 Disclosure of transactions between related parties [abstract] Abstract ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract
149 TRANSACTIONS AND BALANCES WITH RELATED PARTIES Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfRelatedPartyExplanatory
150 00000021 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformation
151 Implied Table Table

*

*

 implied:Table
152 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
153 SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION Concept (Text Block (HTML)) For Period blrx:DisclosureOfSupplementaryFinancialStatementInformationExplanatory
154 00000024 - Disclosure - AGALIMMUNE ACQUISITION Network

*

*

 http://biolinerx.com/role/AgalimmuneAcquisition
155 Implied Table Table

*

*

 implied:Table
156 Disclosure of Agalimmune Acquisition [Abstract] Abstract blrx:DisclosureOfAgalimmuneAcquisitionAbstract
157 AGALIMMUNE ACQUISITION Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfBusinessCombinationsExplanatory
158 00000025 - Disclosure - AMENDMENT TO BL-8040 LICENSE AND LONG-TERM LOAN Network

*

*

 http://biolinerx.com/role/AmendmentToBl-8040LicenseAndLong-termLoan
159 Implied Table Table

*

*

 implied:Table
160 Disclosure of amendment to license [Abstract] Abstract blrx:DisclosureOfAmendmentToLicenseAbstract
161 AMENDMENT TO BL-8040 LICENSE AND LONG-TERM LOAN Concept (Text Block (HTML)) For Period blrx:DisclsoureOfAmendmentToLicenseExplanatory
162 00000026 - Disclosure - EVENT SUBSEQUENT TO THE BALANCE SHEET DATE Network

*

*

 http://biolinerx.com/role/EventSubsequentToBalanceSheetDate
163 Implied Table Table

*

*

 implied:Table
164 Disclosure of event subsequent to the balance sheet date [Abstract] Abstract blrx:DisclosureOfEventsSubsequentToBalanceSheetDateAbstract
165 EVENT SUBSEQUENT TO THE BALANCE SHEET DATE Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory
166 00000027 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Network

*

*

 http://biolinerx.com/role/SignificantAccountingPoliciesPolicies
167 Implied Table Table

*

*

 implied:Table
168 Disclosure of significant accounting policies [Abstract] Abstract blrx:DisclosureOfSignificantAccountingPoliciesAbstract
169 Basis of presentation Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements
170 Principles of consolidation Concept (Text Block (HTML)) For Period blrx:DescriptionOfAccountingPolicyForPrinciplesOfConsolidationAndEquityAccountingExplanatory
171 Consolidation of the financial statements Concept (Text Block (HTML)) For Period blrx:DescriptionOfAccountingPolicyForConsolidationOftheFinancialStatementsExplanatory
172 Functional and reporting currency Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory
173 Cash equivalents and short-term bank deposits Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents
174 Property and equipment Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
175 Intangible assets Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
176 Impairment of non-financial assets Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory
177 Financial assets Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory
178 Warrants Concept (Text Block (HTML)) For Period blrx:DescriptionOfAccountingPolicyForWarrantExplanatory
179 Share capital Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory
180 Trade payables Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory
181 Deferred taxes Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory
182 Revenue from contract with customers Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
183 Research and development expenses Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory
184 Employee benefits Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory
185 Loss per share Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory
186 Standards and interpretations to existing standards that are not yet in effect and have not been early adopted by the Company Concept (Text Block (HTML)) For Period blrx:DescriptionOfAccountingPolicyForChangeInAccountingPolicyAndDisclosuresExplanatory
187 00000028 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Network

*

*

 http://biolinerx.com/role/SignificantAccountingPoliciesTables
188 Implied Table Table

*

*

 implied:Table
189 Disclosure of significant accounting policies [Abstract] Abstract blrx:DisclosureOfSignificantAccountingPoliciesAbstract
190 Schedule of Depreciation Rates Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory
191 00000029 - Disclosure - FINANCIAL RISK MANAGEMENT (Tables) Network

*

*

 http://biolinerx.com/role/FinancialRiskManagementTables
192 Implied Table Table

*

*

 implied:Table
193 Disclosure of detailed information about financial instruments [abstract] Abstract ifrs-full:DisclosureOfFinancialInstrumentsAbstract
194 Schedule of Sensitivity Analysis Concept (Text Block (HTML)) For Period ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk
195 Schedule of Concentration of Currency Risk Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutConcentrationOfCurrencyRiskExplanatory
196 Schedule of Linkage of Monetary Items Concept (Text Block (HTML)) For Period blrx:DisclosureOfClassificationOfFinancialAssetsAndLiabilitiesExplanatory
197 Schedule of Credit Risk Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory
198 00000030 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) Network

*

*

 http://biolinerx.com/role/CashAndCashEquivalentsTables
199 Implied Table Table

*

*

 implied:Table
200 Cash and cash equivalents [abstract] Abstract ifrs-full:CashAndCashEquivalentsAbstract
201 Schedule of Cash And Cash Equivalents Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory
202 00000031 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Network

*

*

 http://biolinerx.com/role/PropertyAndEquipmentTables
203 Implied Table Table

*

*

 implied:Table
204 Disclosure of detailed information about property, plant and equipment [abstract] Abstract ifrs-full:DisclosureOfPropertyPlantAndEquipmentAbstract
205 Schedule of Composition of Property and Equipment and Related Accumulated Depreciation Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
206 00000032 - Disclosure - INTANGIBLE ASSETS (Tables) Network

*

*

 http://biolinerx.com/role/IntangibleAssetsTables
207 Implied Table Table

*

*

 implied:Table
208 Disclosure of detailed information about intangible assets [abstract] Abstract ifrs-full:DisclosureOfIntangibleAssetsAbstract
209 Schedule of Intangible Assets Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
210 00000033 - Disclosure - LONG-TERM LOANS (Tables) Network

*

*

 http://biolinerx.com/role/Long-termLoansTables
211 Implied Table Table

*

*

 implied:Table
212 Disclosure of detailed information about borrowings [abstract] Abstract ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsAbstract
213 Schedule of Composition of Long-Term Bank Loan Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory
214 Schedule of Future Repayments of Long-Term Bank Loan Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutFutureRepaymentsOfLongtermBankLoanExplanatory
215 00000034 - Disclosure - EQUITY (Tables) Network

*

*

 http://biolinerx.com/role/EquityTables
216 Implied Table Table

*

*

 implied:Table
217 Disclosure of classes of share capital [abstract] Abstract ifrs-full:DisclosureOfClassesOfShareCapitalAbstract
218 Schedule of Share Capital Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory
219 Schedule of Amounts Outstanding Under Employee Share Incentive Plan Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
220 Schedule of Options Outstanding by Exercise Price Range Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
221 Schedule of Assumptions Used to Value Options Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
222 00000035 - Disclosure - TAXES ON INCOME (Tables) Network

*

*

 http://biolinerx.com/role/TaxesOnIncomeTables
223 Implied Table Table

*

*

 implied:Table
224 Disclosure of taxes on income [Abstract] Abstract blrx:DisclosureOfIncomeTaxesAbstract
225 Schedule of Reconciliation of Weighted Average Tax Rate Applicable to Income Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutWeightedAverageTaxRateApplicableToIncomeExplanatory
226 00000036 - Disclosure - LOSS PER SHARE (Tables) Network

*

*

 http://biolinerx.com/role/LossPerShareTables
227 Implied Table Table

*

*

 implied:Table
228 Earnings per share [abstract] Abstract ifrs-full:EarningsPerShareAbstract
229 Schedule of Basic Loss Per Share Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutBasicLossPerShareExplanatory
230 00000037 - Disclosure - TRANSACTIONS AND BALANCES WITH RELATED PARTIES (Tables) Network

*

*

 http://biolinerx.com/role/TransactionsAndBalancesWithRelatedPartiesTables
231 Implied Table Table

*

*

 implied:Table
232 Disclosure of transactions between related parties [abstract] Abstract ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract
233 Schedule of Transactions With Related Parties Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory
234 Schedule of Key Management Compensation Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory
235 00000038 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationTables
236 Implied Table Table

*

*

 implied:Table
237 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
238 Schedule of Other Receivables Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory
239 Schedule of Accounts Payable and Accruals Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutAccountsPayableAndAccrualsExplanatory
240 Schedule of Income and Expenses Concept (Text Block (HTML)) For Period blrx:DisclosureOfDetailedInformationAboutIncomeAndExpensesExplanatory
241 00000039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) Network

*

*

 http://biolinerx.com/role/SignificantAccountingPoliciesNarrativeDetails
242 Disclosure of detailed information about intangible assets [table] Table

*

*

 ifrs-full:DisclosureOfIntangibleAssetsTable
243 Intangible assets with indefinite useful life [Axis] Axis ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis
244 Intangible assets with indefinite useful life [member] Member ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeMember
245 Computer software [Member] Member ifrs-full:ComputerSoftwareMember
246 Non-adjusting events after reporting period [axis] Axis ifrs-full:NonadjustingEventsAfterReportingPeriodAxis
247 Non-adjusting events after reporting period [member] Member ifrs-full:NonadjustingEventsMember
248 IFRS 16 [Member] Member ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember
249 Disclosure of detailed information about intangible assets [line items] LineItems ifrs-full:DisclosureOfIntangibleAssetsLineItems
250 Estimated useful lives of intangible assets (In years) Concept (Text/String) For Period ifrs-full:UsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwill
251 Employee benefit expense Concept (Monetary) For Period Debit ifrs-full:EmployeeBenefitsExpense
252 Right-of-use assets Concept (Monetary) As Of Debit ifrs-full:RightofuseAssets
253 Lease liabilities Concept (Monetary) As Of Credit ifrs-full:LeaseLiabilities
254 Increase in Operating cash flows Concept (Monetary) For Period ifrs-full:CashFlowsFromUsedInOperatingActivities
255 Increase in Financing cash flows Concept (Monetary) For Period Debit ifrs-full:CashFlowsFromUsedInFinancingActivities
256 00000040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Depreciation Rates) (Details) Network

*

*

 http://biolinerx.com/role/SignificantAccountingPoliciesScheduleOfDepreciationRatesDetails
257 Disclosure of detailed information about property, plant and equipment [table] Table

*

*

 ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable
258 Classes of property, plant and equipment [Axis] Axis ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis
259 Property, plant and equipment [member] Member ifrs-full:PropertyPlantAndEquipmentMember
260 Computers and communications equipment [Member] Member ifrs-full:ComputerEquipmentMember
261 Office furniture and equipment [Member] Member ifrs-full:OfficeEquipmentMember
262 Laboratory equipment [Member] Member blrx:LaboratoryEquipmentMember
263 Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Axis] Axis ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis
264 Carrying amount [member] Member ifrs-full:CarryingAmountMember
265 Net book value [Member] Member blrx:NetBookValueMember
266 Disclosure of detailed information about property, plant and equipment [line items] LineItems ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems
267 Depreciation rates (in %) Concept (Text/String) For Period ifrs-full:UsefulLivesOrDepreciationRatesPropertyPlantAndEquipment
268 00000041 - Disclosure - FINANCIAL RISK MANAGEMENT (Schedule of Sensitivity Analysis) (Details) Network

*

*

 http://biolinerx.com/role/FinancialRiskManagementScheduleOfSensitivityAnalysisDetails
269 Disclosure of detailed information about financial instruments [table] Table

*

*

 ifrs-full:DisclosureOfFinancialInstrumentsTable
270 Classes of financial instruments [Axis] Axis ifrs-full:ClassesOfFinancialInstrumentsAxis
271 Financial instruments, class [member] Member ifrs-full:ClassesOfFinancialInstrumentsMember
272 Cash and cash equivalents [Member] Member blrx:CashAndCashEquivalentMember
273 Other receivables [Member] Member blrx:OtherReceivablesMember
274 Trade payables [Member] Member blrx:TradePayablesMember
275 Other payables [Member] Member blrx:OtherPayablesMember
276 NIS-linked balances [Member] Member blrx:NisLinkedBalancesMember
277 Euro-linked trade payables [Member] Member blrx:EuroLinkedTradePayablesMember
278 Total [Member] Member blrx:NetMember
279 Disclosure of detailed information about financial instruments [line items] LineItems ifrs-full:DisclosureOfFinancialInstrumentsLineItems
280 10% increase effect on net income (loss) and equity Concept (Monetary) As Of Credit blrx:TenPercentIncreaseEffectOnNetIncomeLossAndEquity
281 5% increase effect on net income (loss) and equity Concept (Monetary) As Of Credit blrx:FivePercentIncreaseEffectOnNetIncomeLossAndEquity
282 Value on balance sheet Concept (Monetary) As Of Credit ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads
283 5% decrease effect on net income (loss) and equity Concept (Monetary) As Of Credit blrx:FivePercentDecreaseEffectOnNetIncomeLossAndEquity
284 10% decrease effect on net income (loss) and equity Concept (Monetary) As Of Credit blrx:TenPercentDecreaseEffectOnNetIncomeLossAndEquity
285 00000042 - Disclosure - FINANCIAL RISK MANAGEMENT (Schedule of Concentration of Currency Risk) (Details) Network

*

*

 http://biolinerx.com/role/FinancialRiskManagementScheduleOfConcentrationOfCurrencyRiskDetails
286 Disclosure of risk management strategy related to hedge accounting [table] Table

*

*

 ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable
287 Types of risks [Axis] Axis ifrs-full:TypesOfRisksAxis
288 Risks [member] Member ifrs-full:TypesOfRisksMember
289 NIS per $1 Member blrx:NisPerDollarMember
290 Euro per $1 Member blrx:EuroPerDollarMember
291 Disclosure of risk management strategy related to hedge accounting [line items] LineItems ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems
292 Exchange rate per dollar Concept (Decimal) As Of ifrs-full:ClosingForeignExchangeRate
293 Percentage increase (decrease) in exchange rate Concept (Percent) As Of blrx:PercentageIncreaseDecreaseInExchangeRate
294 00000043 - Disclosure - FINANCIAL RISK MANAGEMENT (Schedule of Linkage of Monetary Items) (Details) Network

*

*

 http://biolinerx.com/role/FinancialRiskManagementScheduleOfLinkageOfMonetaryItemsDetails
295 Disclosure of risk management strategy related to hedge accounting [table] Table

*

*

 ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable
296 Types of risks [Axis] Axis ifrs-full:TypesOfRisksAxis
297 Risks [member] Member ifrs-full:TypesOfRisksMember
298 Dollar [Member] Member blrx:DollarMember
299 NIS [Member] Member blrx:NisMember
300 GBP and other [Member] Member blrx:OtherCurrenciesMember
301 Disclosure of risk management strategy related to hedge accounting [line items] LineItems ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems
302 Assets: Abstract ifrs-full:AssetsAbstract
303 Current assets: Abstract ifrs-full:CurrentAssetsAbstract
304 Cash and cash equivalents Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
305 Short term bank deposits Concept (Monetary) As Of Debit ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
306 Other receivables Concept (Monetary) As Of Debit ifrs-full:OtherReceivables
307 Total assets Concept (Monetary) As Of Debit ifrs-full:Assets
308 Liabilities: Abstract ifrs-full:LiabilitiesAbstract
309 Current liabilities: Abstract ifrs-full:CurrentLiabilitiesAbstract
310 Current maturities of bank loan Concept (Monetary) As Of Credit ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
311 Accounts payable and accruals: Abstract ifrs-full:TradeAndOtherPayablesAbstract
312 Trade Concept (Monetary) As Of Credit ifrs-full:TradeAndOtherPayablesToTradeSuppliers
313 Other Concept (Monetary) As Of Credit ifrs-full:OtherPayables
314 Non-current liabilities Abstract ifrs-full:NoncurrentLiabilitiesAbstract
315 Long-term bank loan, net of current maturities Concept (Monetary) As Of Credit ifrs-full:NoncurrentPortionOfNoncurrentLoansReceived
316 Total liabilities Concept (Monetary) As Of Credit ifrs-full:Liabilities
317 Net asset value Concept (Monetary) As Of Debit blrx:NetAssetValueOfLinkageMonetaryItems
318 00000044 - Disclosure - FINANCIAL RISK MANAGEMENT (Schedule of Credit Risk) (Details) Network

*

*

 http://biolinerx.com/role/FinancialRiskManagementScheduleOfCreditRiskDetails
319 Disclosure of risk management strategy related to hedge accounting [table] Table

*

*

 ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable
320 Types of risks [Axis] Axis ifrs-full:TypesOfRisksAxis
321 Risks [member] Member ifrs-full:TypesOfRisksMember
322 Credit risk [member] Member ifrs-full:CreditRiskMember
323 Disclosure of risk management strategy related to hedge accounting [line items] LineItems ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems
324 Assets: Abstract ifrs-full:AssetsAbstract
325 Cash and cash equivalents Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
326 Short term bank deposits Concept (Monetary) As Of Debit ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
327 Other receivables Concept (Monetary) As Of Debit ifrs-full:OtherReceivables
328 Total assets Concept (Monetary) As Of Debit ifrs-full:Assets
329 00000045 - Disclosure - CASH AND CASH EQUIVALENTS (Narrative) (Details) Network

*

*

 http://biolinerx.com/role/CashAndCashEquivalentsNarrativeDetails
330 Implied Table Table

*

*

 implied:Table
331 Cash and cash equivalents [abstract] Abstract ifrs-full:CashAndCashEquivalentsAbstract
332 Interest rate on short-term deposits Concept (Percent) For Period blrx:InterestRateOnShorttermDepositsIncludesCashAndCashEquivalents
333 00000046 - Disclosure - CASH AND CASH EQUIVALENTS (Schedule of Cash And Cash Equivalents) (Details) Network

*

*

 http://biolinerx.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails
334 Implied Table Table

*

*

 implied:Table
335 Cash and cash equivalents [abstract] Abstract ifrs-full:CashAndCashEquivalentsAbstract
336 Cash on hand and in bank Concept (Monetary) As Of Debit ifrs-full:Cash
337 Short-term bank deposits Concept (Monetary) As Of Debit ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
338 Cash and cash equivalents Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
339 00000047 - Disclosure - SHORT-TERM BANK DEPOSITS (Narrative) (Details) Network

*

*

 http://biolinerx.com/role/Short-termBankDepositsNarrativeDetails
340 Disclosure of detailed information about financial instruments [table] Table

*

*

 ifrs-full:DisclosureOfFinancialInstrumentsTable
341 Range [Axis] Axis ifrs-full:RangeAxis
342 Ranges [member] Member ifrs-full:RangesMember
343 Bottom of range [Member] Member ifrs-full:BottomOfRangeMember
344 Top of range [Member] Member ifrs-full:TopOfRangeMember
345 Disclosure of detailed information about financial instruments [line items] LineItems ifrs-full:DisclosureOfFinancialInstrumentsLineItems
346 Interest rate on short-term deposits Concept (Percent) For Period blrx:InterestRateOnShorttermDeposits
347 00000048 - Disclosure - LONG-TERM INVESTMENT (Details) Network

*

*

 http://biolinerx.com/role/Long-termInvestmentDetails
348 Disclosure of joint ventures [table] Table

*

*

 ifrs-full:DisclosureOfJointVenturesTable
349 Joint ventures [Axis] Axis ifrs-full:JointVenturesAxis
350 Entity's total for joint ventures [member] Member ifrs-full:EntitysTotalForJointVenturesMember
351 I-Bridge Capital [Member] Member blrx:IBridgeCapitalMember
352 Disclosure of joint ventures [line items] LineItems ifrs-full:DisclosureOfJointVenturesLineItems
353 Initial seed capital to joint venture Concept (Monetary) As Of Debit ifrs-full:LongtermDeposits
354 Cash consideration to joint venture Concept (Monetary) For Period Debit ifrs-full:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities
355 Net gain Concept (Monetary) For Period Debit ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities
356 00000049 - Disclosure - PROPERTY AND EQUIPMENT (Schedule of Composition of Property and Equipment and Related Accumulated Depreciation) (Details) Network

*

*

 http://biolinerx.com/role/PropertyAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentAndRelatedAccumulatedDepreciationDetails
357 Disclosure of detailed information about property, plant and equipment [table] Table

*

*

 ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable
358 Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Axis] Axis ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis
359 Carrying amount [member] Member ifrs-full:CarryingAmountMember
360 Cost [Member] Member ifrs-full:GrossCarryingAmountMember
361 Accumulated depreciation [member] Member ifrs-full:AccumulatedDepreciationAndAmortisationMember
362 Net book value [Member] Member blrx:NetBookValueMember
363 Classes of property, plant and equipment [Axis] Axis ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis
364 Property, plant and equipment [member] Member ifrs-full:PropertyPlantAndEquipmentMember
365 Office furniture and equipment [Member] Member ifrs-full:OfficeEquipmentMember
366 Computers and communications equipment [Member] Member ifrs-full:ComputerEquipmentMember
367 Laboratory equipment [Member] Member blrx:LaboratoryEquipmentMember
368 Leasehold improvements [Member] Member ifrs-full:LeaseholdImprovementsMember
369 Disclosure of detailed information about property, plant and equipment [line items] LineItems ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems
370 Balance at beginning year Concept (Monetary) As Of Debit ifrs-full:PropertyPlantAndEquipment
371 Additions during year Concept (Monetary) For Period Debit ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
372 Deletions during year Concept (Monetary) For Period Credit ifrs-full:DisposalsPropertyPlantAndEquipment
373 Balance at end of year Concept (Monetary) As Of Debit ifrs-full:PropertyPlantAndEquipment
374 00000050 - Disclosure - INTANGIBLE ASSETS (Schedule of Intangible Assets) (Details) Network

*

*

 http://biolinerx.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails
375 Disclosure of detailed information about intangible assets [table] Table

*

*

 ifrs-full:DisclosureOfIntangibleAssetsTable
376 Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Axis] Axis ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis
377 Carrying amount [member] Member ifrs-full:CarryingAmountMember
378 Net book value [Member] Member blrx:NetBookValueMember
379 Cost [Member] Member ifrs-full:GrossCarryingAmountMember
380 Accumulated depreciation and impairmentt [Member] Member ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
381 Classes of intangible assets other than goodwill [Axis] Axis ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis
382 Intangible assets other than goodwill [member] Member ifrs-full:IntangibleAssetsOtherThanGoodwillMember
383 Intellectual property [Member] Member ifrs-full:OtherIntangibleAssetsMember
384 Computer software [Member] Member ifrs-full:ComputerSoftwareMember
385 Disclosure of detailed information about intangible assets [line items] LineItems ifrs-full:DisclosureOfIntangibleAssetsLineItems
386 Balance at beginning year Concept (Monetary) As Of Debit ifrs-full:IntangibleAssetsOtherThanGoodwill
387 Additions during year Concept (Monetary) For Period Debit ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
388 Deletions during year Concept (Monetary) For Period Credit ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill
389 Balance at end of year Concept (Monetary) As Of Debit ifrs-full:IntangibleAssetsOtherThanGoodwill
390 00000051 - Disclosure - LONG-TERM LOANS (Narrative) (Details) Network

*

*

 http://biolinerx.com/role/Long-termLoansNarrativeDetails
391 Implied Table Table

*

*

 implied:Table
392 Disclosure of detailed information about borrowings [abstract] Abstract ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsAbstract
393 Interest rate on long term bank loan Concept (Percent) As Of blrx:InterestRateOnLongTermBankLoan
394 00000052 - Disclosure - LONG-TERM LOANS (Schedule of Composition of Long-Term Loans) (Details) Network

*

*

 http://biolinerx.com/role/Long-termLoansScheduleOfCompositionOfLong-termLoansDetails
395 Disclosure of detailed information about borrowings [table] Table

*

*

 ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable
396 Borrowings by name [Axis] Axis ifrs-full:BorrowingsByNameAxis
397 Borrowings by name [member] Member ifrs-full:BorrowingsByNameMember
398 Bank Loan [Member] Member blrx:BankLoanMember
399 Loan from Kreos Capital [Member] Member blrx:KreosLoanMember
400 Disclosure of detailed information about borrowings [line items] LineItems ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems
401 Loan Concept (Monetary) As Of Credit ifrs-full:Borrowings
402 Less current maturities Concept (Monetary) As Of Credit ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
403 Long-term bank loan, net of current maturities Concept (Monetary) As Of Credit ifrs-full:NoncurrentPortionOfNoncurrentLoansReceived
404 00000053 - Disclosure - LONG-TERM LOANS (Schedule of Future Repayments of Long-Term Loans) (Details) Network

*

*

 http://biolinerx.com/role/Long-termLoansScheduleOfFutureRepaymentsOfLong-termLoansDetails
405 Disclosure of detailed information about borrowings [table] Table

*

*

 ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable
406 Borrowings by name [Axis] Axis ifrs-full:BorrowingsByNameAxis
407 Borrowings by name [member] Member ifrs-full:BorrowingsByNameMember
408 Bank Loan [Member] Member blrx:BankLoanMember
409 Loan from Kreos Capital [Member] Member blrx:KreosLoanMember
410 Disclosure of detailed information about borrowings [line items] LineItems ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems
411 2020 Concept (Monetary) As Of Credit blrx:RepaymentOfLongTermDebtAfterOneYear
412 2021 Concept (Monetary) As Of Credit blrx:RepaymentOfLongTermDebtYearsTwo
413 2022 Concept (Monetary) As Of Credit blrx:RepaymentOfLongTermDebtYearsThree
414 Future repayments of long-term bank loan Concept (Monetary) As Of Credit ifrs-full:NoncurrentPortionOfNoncurrentLoansReceived
415 00000054 - Disclosure - EQUITY (Narrative) (Details) Network

*

*

 http://biolinerx.com/role/EquityNarrativeDetails
416 Disclosure of terms and conditions of share-based payment arrangement [table] Table

*

*

 ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable
417 Types of share-based payment arrangements [Axis] Axis ifrs-full:TypesOfSharebasedPaymentArrangementsAxis
418 Share-based payment arrangements [member] Member ifrs-full:SharebasedPaymentArrangementsMember
419 NASDAQ [Member] Member blrx:AmericanStockExchangeMember
420 TASE [Member] Member blrx:TelAvivStockExchangeMember
421 2003 Plan [Member] Member blrx:ShareIncentivePlanMember
422 PSU [Member] Member blrx:PerformanceStockUnitsMember
423 Types of investment property [Axis] Axis ifrs-full:TypesOfInvestmentPropertyAxis
424 Investment property [member] Member ifrs-full:InvestmentPropertyMember
425 Direct Placement [Member] Member blrx:DirectPlacementMember
426 OrbiMed Advisors LLC [Member] Member blrx:OrbiMedAdvisorsMember
427 BVF Partners L.P. [Member] Member blrx:BvfPartnersLpMember
428 Lincoln Park Capital Fund [Member] Member blrx:LincolnParkCapitalFundMember
429 Consultants [Member] Member blrx:ConsultantsMember
430 BioLineRx [Member] Member blrx:BioLineRxMember
431 Oberon Securities [Member] Member blrx:OberonSecuritiesMember
432 Components of equity [axis] Axis ifrs-full:ComponentsOfEquityAxis
433 Equity [member] Member ifrs-full:EquityMember
434 Series A [Member] Member blrx:SeriesAWarrantMember
435 Series B [Member] Member blrx:SeriesBWarrantMember
436 Warrant [Member] Member blrx:WarrantOneMember
437 Categories of related parties [Axis] Axis ifrs-full:CategoriesOfRelatedPartiesAxis
438 Entity's total for related parties [member] Member ifrs-full:EntitysTotalForRelatedPartiesMember
439 BTIG, LLC [Member] Member blrx:BtigLlcMember
440 Non-adjusting events after reporting period [axis] Axis ifrs-full:NonadjustingEventsAfterReportingPeriodAxis
441 Non-adjusting events after reporting period [member] Member ifrs-full:NonadjustingEventsMember
442 Additional Shares [Member] Member blrx:AdditionalSharesMember
443 Disclosure of terms and conditions of share-based payment arrangement [line items] LineItems ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
444 Market price of ordinary shares Concept (Share) As Of blrx:MarketSharePrice
445 Shares issued to purchase warrant Concept (Shares) As Of blrx:ShareIssuedToPurchaseWarrant
446 Exercise price of shares issued Concept (Share) As Of blrx:ExercisePriceOfShareIssued
447 Amount allocated to warrant Concept (Monetary) As Of Credit blrx:AmountAllocatedToWarrant
448 Change in fair value Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
449 Maturity date of warrant Concept (Text/String) For Period blrx:MaturityDate
450 Exercisable term of warrant Concept (Text/String) For Period blrx:ExercisableTermOfWarrant
451 Underwritten public offering Concept (Shares) As Of blrx:ShareIssuedOfPublicOffering
452 Public offering price Concept (Share) As Of blrx:StockIssuedPricePerSahre
453 Proceeds from public offering, gross Concept (Monetary) For Period Debit blrx:ProceedsFromIssuanceOfInitialPublicOffering
454 Proceeds from public offering, net Concept (Monetary) For Period Debit blrx:ProceedsFromIssuanceOfInitialPublicOfferingNet
455 Share purchase agreement Concept (Monetary) As Of Credit blrx:SharePurchaseAgreement
456 Share purchase agreement, shares Concept (Shares) As Of blrx:SharePurchaseAgreementShares
457 Purchase agreement period Concept (Text/String) For Period blrx:PurchaseAgreementPeriod
458 Issuance expense Concept (Monetary) For Period Debit ifrs-full:ShareIssueRelatedCost
459 Share issued as additional commitment fee Concept (Shares) For Period blrx:ShareIssuedAsAdditionalCommitmentFee
460 Commitment fee Concept (Monetary) For Period Debit ifrs-full:OtherFeeAndCommissionExpense
461 Additional commitment fee Concept (Monetary) For Period Debit blrx:AdditionalCommitmentFee
462 Non operating expense Concept (Monetary) For Period Debit blrx:NonOperatingExpense
463 Gross proceeds Concept (Monetary) For Period Debit ifrs-full:ProceedsFromIssuingShares
464 Net proceeds from transaction Concept (Monetary) For Period Debit ifrs-full:ProceedsFromIssueOfOrdinaryShares
465 Available balance under the facility Concept (Monetary) For Period Credit blrx:AvailableBalanceUnderFacility
466 Sale of stock Concept (Shares) For Period blrx:SaleOfStockNumberOfSharesIssued
467 Ordinary shares, issued Concept (Shares) As Of ifrs-full:NumberOfSharesIssued
468 Ordinary shares, authorized Concept (Shares) As Of ifrs-full:NumberOfSharesAuthorised
469 Remaining authorized unissued ordinary shares Concept (Shares) As Of blrx:RemainingAuthorizedUnissuedOrdinaryShares
470 Exercise price Concept (Monetary) For Period ifrs-full:ExercisePriceShareOptionsGranted
471 Weighted average exercise price Concept (Monetary) For Period ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement
472 Option vested and exercised Concept (Text/String) For Period ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
473 Option outstanding Concept (Decimal) As Of ifrs-full:NumberOfOutstandingShareOptions
474 Option vested Concept (Decimal) For Period ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
475 Weighted average exercise price Concept (Monetary) For Period ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement
476 Weighted average contractual life Concept (Decimal) As Of ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions
477 Value of services recorded Concept (Monetary) For Period Debit blrx:ValueOfServicesRecorded
478 Amount granted for equity instruments Concept (Monetary) For Period Debit blrx:AmountGrantOfEquityInstruments
479 Risk-free interest rate (%) Concept (Percent) For Period ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
480 Average standard deviation Concept (Percent) For Period ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
481 Aggregate offering price Concept (Monetary) As Of Credit blrx:AggregateOfferingPrice
482 Percentage of commission on sales agreement Concept (Percent) As Of blrx:PercentageOfCommissionOnSalesAgreement
483 Line of credit Concept (Monetary) As Of ifrs-full:CreditExposure
484 00000055 - Disclosure - EQUITY (Schedule of Share Capital) (Details) Network

*

*

 http://biolinerx.com/role/EquityScheduleOfShareCapitalDetails
485 Disclosure of terms and conditions of share-based payment arrangement [table] Table

*

*

 ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable
486 Currency [Axis] Axis srt:CurrencyAxis
487 All Currencies [Domain] Member currency:AllCurrenciesDomain
488 NIS [Member] Member blrx:IsraelNewShekelsMember
489 Disclosure of terms and conditions of share-based payment arrangement [line items] LineItems ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
490 Number of Ordinary Shares Abstract blrx:NumberOfOrdinarySharesAbstract
491 Authorized share capital Concept (Shares) As Of ifrs-full:NumberOfSharesAuthorised
492 Issued and paid-up share capital Concept (Shares) As Of ifrs-full:NumberOfSharesIssuedAndFullyPaid
493 Authorized share capital Concept (Monetary) As Of Credit blrx:AuthorizedShareCapitalValue
494 Issued and paid-up share capital Concept (Monetary) As Of Credit blrx:IssuedAndPaidupShareCapitalValue
495 00000056 - Disclosure - EQUITY (Schedule of Amounts Outstanding Under Employee Share Incentive Plan) (Details) Network

*

*

 http://biolinerx.com/role/EquityScheduleOfAmountsOutstandingUnderEmployeeShareIncentivePlanDetails
496 Disclosure of terms and conditions of share-based payment arrangement [table] Table

*

*

 ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable
497 Types of share-based payment arrangements [Axis] Axis ifrs-full:TypesOfSharebasedPaymentArrangementsAxis
498 Share-based payment arrangements [member] Member ifrs-full:SharebasedPaymentArrangementsMember
499 Employees and Directors [Member] Member blrx:EmployeesAndDirectorsMember
500 Disclosure of terms and conditions of share-based payment arrangement [line items] LineItems ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
501 Number of options Abstract blrx:NumberOfOptionsAbstract
502 Outstanding at beginning of year Concept (Decimal) As Of ifrs-full:NumberOfOutstandingShareOptions
503 Granted Concept (Decimal) For Period ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
504 Forfeited and expired Concept (Decimal) For Period ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
505 Exercised Concept (Decimal) For Period ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
506 Outstanding at end of year Concept (Decimal) As Of ifrs-full:NumberOfOutstandingShareOptions
507 Exercisable at end of year Concept (Decimal) As Of ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
508 Weighted average exercise price (in NIS) Abstract blrx:WeightedAverageExercisePriceAbstract
509 Outstanding at beginning of year Concept (Monetary) As Of ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement
510 Granted Concept (Monetary) For Period ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement
511 Forfeited and expired Concept (Monetary) For Period ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement
512 Exercised Concept (Monetary) For Period ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement
513 Outstanding at end of year Concept (Monetary) As Of ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement
514 Exercisable at end of year Concept (Monetary) As Of ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement
515 00000057 - Disclosure - EQUITY (Schedule of Options Outstanding by Exercise Price Range) (Details) Network

*

*

 http://biolinerx.com/role/EquityScheduleOfOptionsOutstandingByExercisePriceRangeDetails
516 Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Table

*

*

 ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable
517 Ranges of exercise prices for outstanding share options [Axis] Axis ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis
518 Ranges of exercise prices for outstanding share options [member] Member ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsMember
519 Up to 5.00 [Member] Member blrx:ExercisePriceRangeMember
520 5.01-10.00 [Member] Member blrx:ExercisePriceRangeSixMember
521 10.01-20.00 [Member] Member blrx:ExercisePriceRangeOneMember
522 20.01-55.00 [Member] Member blrx:ExercisePriceRangeTwoMember
523 Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] LineItems ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems
524 Number of options outstanding Concept (Decimal) As Of ifrs-full:NumberOfOutstandingShareOptions
525 Weighted average remaining contractual (in Yrs.) Concept (Decimal) As Of ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions
526 00000058 - Disclosure - EQUITY (Schedule of Assumptions Used to Value Options) (Details) Network

*

*

 http://biolinerx.com/role/EquityScheduleOfAssumptionsUsedToValueOptionsDetails
527 Implied Table Table

*

*

 implied:Table
528 Disclosure of classes of share capital [abstract] Abstract ifrs-full:DisclosureOfClassesOfShareCapitalAbstract
529 Expected dividend yield (%) Concept (Percent) For Period ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
530 Expected volatility (%) Concept (Percent) For Period ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
531 Risk-free interest rate (%) Concept (Percent) For Period ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
532 Expected life of options (in years) Concept (Decimal) For Period ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
533 00000059 - Disclosure - TAXES ON INCOME (Narrative) (Details) Network

*

*

 http://biolinerx.com/role/TaxesOnIncomeNarrativeDetails
534 Disclosure of non-adjusting events after reporting period [table] Table

*

*

 ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodTable
535 Geographical areas [Axis] Axis ifrs-full:GeographicalAreasAxis
536 Geographical areas [member] Member ifrs-full:GeographicalAreasMember
537 Israel [Member] Member ifrs-full:CountryOfDomicileMember
538 Non-adjusting events after reporting period [axis] Axis ifrs-full:NonadjustingEventsAfterReportingPeriodAxis
539 Non-adjusting events after reporting period [member] Member ifrs-full:NonadjustingEventsMember
540 Changes in tax rates or tax laws enacted or announced [Member] Member ifrs-full:ChangesInTaxRatesOrTaxLawsEnactedOrAnnouncedMember
541 Disclosure of non-adjusting events after reporting period [line items] LineItems ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems
542 Corporate tax rate Concept (Percent) For Period ifrs-full:ApplicableTaxRate
543 Future enacted tax rate Concept (Percent) For Period blrx:FutureEnactedTaxRate
544 Uniform tax rate Concept (Percent) For Period blrx:UniformTaxRate
545 Withholding income tax rate Concept (Percent) For Period blrx:WithholdingApplicableTaxRate
546 Tax loss carryforwards Concept (Monetary) For Period Debit blrx:TaxLossCarryforwards
547 00000060 - Disclosure - TAXES ON INCOME (Schedule of Reconciliation of Weighted Average Tax Rate Applicable to Income) (Details) Network

*

*

 http://biolinerx.com/role/TaxesOnIncomeScheduleOfReconciliationOfWeightedAverageTaxRateApplicableToIncomeDetails
548 Implied Table Table

*

*

 implied:Table
549 Disclosure of taxes on income [Abstract] Abstract blrx:DisclosureOfIncomeTaxesAbstract
550 Loss before taxes (Percentage) Concept (Percent) For Period ifrs-full:ApplicableTaxRate
551 Loss before taxes Concept (Monetary) For Period Credit ifrs-full:AccountingProfit
552 Theoretical tax benefit Concept (Monetary) For Period Debit ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
553 Disallowed deductions (tax exempt income): Abstract blrx:DisallowedDeductionsTaxExemptIncomeAbstract
554 Loss (gain) on adjustment of warrants to fair value Concept (Monetary) For Period Debit blrx:TaxEffectOfGainOnAdjustmentOfWarrantsFairValueExemptFromTaxation
555 Share-based compensation Concept (Monetary) For Period Debit blrx:TaxEffectOfSharebasedCompensationExemptFromTaxation
556 Other Concept (Monetary) For Period Debit ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
557 Increase in taxes for tax losses and timing differences incurred in the reporting year for which deferred taxes were not created Concept (Monetary) For Period Debit blrx:IncreaseInTaxesForTaxLossesAndTimingDifferencesIncurredInReportingYearForWhichDeferredTaxesWereNotCreated
558 Taxes on income for the reported year Concept (Monetary) For Period Debit ifrs-full:IncomeTaxExpenseContinuingOperations
559 00000061 - Disclosure - LOSS PER SHARE (Schedule of Basic Loss Per Share) (Details) Network

*

*

 http://biolinerx.com/role/LossPerShareScheduleOfBasicLossPerShareDetails
560 Implied Table Table

*

*

 implied:Table
561 Earnings per share [abstract] Abstract ifrs-full:EarningsPerShareAbstract
562 Loss attributed to ordinary shares Concept (Monetary) For Period Credit ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
563 Number of shares used in basic calculation Concept (Shares) For Period ifrs-full:WeightedAverageShares
564 Basic and diluted loss per ordinary share Concept (Share) For Period ifrs-full:BasicAndDilutedEarningsLossPerShare
565 00000062 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details) Network

*

*

 http://biolinerx.com/role/CommitmentsAndContingentLiabilitiesDetails
566 Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table] Table

*

*

 ifrs-full:DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable
567 Maturity [axis] Axis ifrs-full:MaturityAxis
568 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
569 First three years [Member] Member blrx:FirstTthreeYearsMember
570 Three subsequent years [Member] Member blrx:ThreeSubsequentYearsMember
571 Seventh year [Member] Member blrx:SeventhYearMember
572 Phase 2 [Member] Member blrx:PhaseTwoMember
573 Phase 3 [Member] Member blrx:PhaseThreeMember
574 2019 [Member] Member ifrs-full:NotLaterThanOneYearMember
575 2020 [Member] Member ifrs-full:LaterThanOneYearMember
576 Range [Axis] Axis ifrs-full:RangeAxis
577 Ranges [member] Member ifrs-full:RangesMember
578 Bottom of range [Member] Member ifrs-full:BottomOfRangeMember
579 Top of range [Member] Member ifrs-full:TopOfRangeMember
580 Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] LineItems ifrs-full:DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateLineItems
581 Royalties received percentage Concept (Percent) For Period blrx:RoyaltiesReceivedPercentage
582 Contingent liability Concept (Monetary) As Of ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
583 Licensing agreements - One time payment Concept (Monetary) For Period Credit blrx:LicensingAgreementsOneTimePayment
584 Licensing agreements - Periodic payment Concept (Monetary) For Period Credit blrx:LicensingAgreementsPeriodicPayment
585 Royalties on sale Concept (Percent) For Period blrx:RoyaltiesOnSale
586 Percentage of net consideration received from the licensee Concept (Percent) For Period blrx:PercentageOfNetConsiderationReceivedFromLicensee
587 Lease agreement monthly fee Concept (Monetary) For Period Debit blrx:LeaseAgreementMonthlyFee
588 Additional extension period Concept (xbrli:durationItemType) For Period blrx:AdditionalExtendLeasePeriod
589 Percentage Increase preceding lease payment amount Concept (Percent) For Period blrx:PercentageIncreasePrecedingLeasePaymentAmount
590 Lease Period Concept (xbrli:durationItemType) For Period blrx:LeasePeriod
591 Annual Lease fee Concept (Monetary) For Period Debit blrx:AnnualLeaseFee
592 Bank guarantee amount for benefit of lessor Concept (Monetary) For Period Debit blrx:BankGuaranteeAmountForBenefitOfLessor
593 Company's outstanding open purchase order commitments Concept (Monetary) As Of Credit blrx:OpenPurchaseOrderCommitments
594 Minimum future rental payments Concept (Monetary) As Of Credit ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease
595 00000063 - Disclosure - TRANSACTIONS AND BALANCES WITH RELATED PARTIES (Schedule of Transactions With Related Parties) (Details) Network

*

*

 http://biolinerx.com/role/TransactionsAndBalancesWithRelatedPartiesScheduleOfTransactionsWithRelatedPartiesDetails
596 Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table] Table

*

*

 ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable
597 Separate management entities [Axis] Axis ifrs-full:SeparateManagementEntitiesAxis
598 Separate management entities [member] Member ifrs-full:SeparateManagementEntitiesMember
599 Senior Management [Member] Member blrx:SeniorManagementMember
600 Director [Member] Member blrx:DirectorsMember
601 Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items] LineItems ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems
602 Benefits to related parties: Abstract blrx:BenefitsToRelatedPartiesAbstract
603 Compensation and benefits to management, including benefit component of equity instrument grants Concept (Monetary) For Period Debit ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
604 Number of individuals to which this benefit related Concept (Decimal) As Of ifrs-full:NumberOfEmployees
605 00000064 - Disclosure - TRANSACTIONS AND BALANCES WITH RELATED PARTIES (Schedule of Key Management Compensation) (Details) Network

*

*

 http://biolinerx.com/role/TransactionsAndBalancesWithRelatedPartiesScheduleOfKeyManagementCompensationDetails
606 Implied Table Table

*

*

 implied:Table
607 Disclosure of transactions between related parties [abstract] Abstract ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract
608 Salaries and other short-term employee benefits Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
609 Post-employment benefits Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
610 Other long-term benefits Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits
611 Share-based compensation Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
612 Benefits to key executive personnel Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensation
613 00000065 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of Other Receivables) (Details) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationScheduleOfOtherReceivablesDetails
614 Implied Table Table

*

*

 implied:Table
615 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
616 Government institutions Concept (Monetary) As Of Debit blrx:InstitutionsCurrentReceivables
617 Other Concept (Monetary) As Of Debit blrx:Other
618 Other receivables Concept (Monetary) As Of Debit ifrs-full:OtherCurrentReceivables
619 00000066 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of Accounts Payable and Accruals) (Details) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationScheduleOfAccountsPayableAndAccrualsDetails
620 Implied Table Table

*

*

 implied:Table
621 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
622 Trade: Abstract blrx:TradePayablesAbstract
623 Accounts payable: Abstract blrx:AccountsPayableAbstract
624 Overseas Concept (Monetary) As Of Credit blrx:TradeAndOtherPayablesToForeignTradeSuppliers
625 In Israel Concept (Monetary) As Of Credit blrx:TradeAndOtherPayablesToLocalTradeSuppliers
626 Trade Concept (Monetary) As Of Credit ifrs-full:TradeAndOtherPayablesToTradeSuppliers
627 Other: Abstract blrx:OtherPayablesAbstract
628 Accrued expenses Concept (Monetary) As Of Credit ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
629 Accrual for vacation and recreation pay Concept (Monetary) As Of Credit ifrs-full:CurrentProvisionsForEmployeeBenefits
630 Payroll and related expenses Concept (Monetary) As Of Credit blrx:PayrollAndRelatedExpenses
631 Other Concept (Monetary) As Of Credit ifrs-full:OtherPayables
632 Other Concept (Monetary) As Of Credit ifrs-full:OtherCurrentPayables
633 00000067 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of Research and Development Expenses) (Details) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationScheduleOfResearchAndDevelopmentExpensesDetails
634 Implied Table Table

*

*

 implied:Table
635 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
636 Research and development services Concept (Monetary) For Period Debit ifrs-full:ServicesExpense
637 Payroll and related expenses Concept (Monetary) For Period Debit ifrs-full:ShorttermEmployeeBenefitsExpense
638 Lab, occupancy and telephone Concept (Monetary) For Period Debit ifrs-full:CommunicationExpense
639 Professional fees Concept (Monetary) For Period Debit blrx:ProfessionalFee
640 Depreciation and amortization Concept (Monetary) For Period Debit ifrs-full:DepreciationAndAmortisationExpense
641 Write-off of intellectual property Concept (Monetary) For Period Debit blrx:WriteoffOfIntellectualProperty
642 Other Concept (Monetary) For Period Debit ifrs-full:OtherExpenseByNature
643 Research and development expenses Concept (Monetary) For Period Debit ifrs-full:ResearchAndDevelopmentExpense
644 00000068 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of Sales and Marketing Expenses) (Details) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationScheduleOfSalesAndMarketingExpensesDetails
645 Implied Table Table

*

*

 implied:Table
646 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
647 Payroll and related expenses Concept (Monetary) For Period Debit blrx:SalesAndMarketingPayrollExpense
648 Marketing Concept (Monetary) For Period Debit blrx:MarketingExpenses
649 Overseas travel Concept (Monetary) For Period Debit ifrs-full:TravelExpense
650 Sales and marketing expenses Concept (Monetary) For Period Debit ifrs-full:SalesAndMarketingExpense
651 00000069 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of General and Administrative Expense) (Details) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationScheduleOfGeneralAndAdministrativeExpenseDetails
652 Implied Table Table

*

*

 implied:Table
653 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
654 Payroll and related expenses Concept (Monetary) For Period Debit ifrs-full:WagesAndSalaries
655 Professional fees Concept (Monetary) For Period Debit ifrs-full:ProfessionalFeesExpense
656 Insurance Concept (Monetary) For Period Debit ifrs-full:InsuranceExpense
657 Depreciation Concept (Monetary) For Period Debit ifrs-full:DepreciationExpense
658 Other Concept (Monetary) For Period Debit ifrs-full:OtherExpenseByFunction
659 General and administrative expenses Concept (Monetary) For Period Debit ifrs-full:SellingGeneralAndAdministrativeExpense
660 00000070 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of Non-Operating Income (Expenses), Net) (Details) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationScheduleOfNon-operatingIncomeExpensesNetDetails
661 Implied Table Table

*

*

 implied:Table
662 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
663 Issuance costs Concept (Monetary) For Period Debit ifrs-full:ShareIssueRelatedCost
664 Changes in fair value of warrants Concept (Monetary) For Period Credit ifrs-full:IncreaseDecreaseInFairValueMeasurementLiabilities
665 Gain from realization of long-term investment Concept (Monetary) For Period Credit blrx:GainOnRealizationOfLongtermInvestment
666 Initial commitment and finder's fees associated with LPC agreement Concept (Monetary) For Period ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions
667 Other Concept (Monetary) For Period Credit ifrs-full:OtherIncome
668 Non-operating income, net Concept (Monetary) For Period Credit blrx:ProfitLossFromNonOperatingActivities
669 00000071 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of Financial Income) (Details) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationScheduleOfFinancialIncomeDetails
670 Implied Table Table

*

*

 implied:Table
671 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
672 Interest income and exchange differences Concept (Monetary) For Period Credit blrx:InterestIncomeAndExchangeDifferences
673 Gain on foreign currency hedging Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnChangeInValueOfForeignCurrencyBasisSpreadsBeforeTax
674 Financial income Concept (Monetary) For Period Credit ifrs-full:FinanceIncome
675 00000072 - Disclosure - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of Financial Expenses) (Details) Network

*

*

 http://biolinerx.com/role/SupplementaryFinancialStatementInformationScheduleOfFinancialExpensesDetails
676 Implied Table Table

*

*

 implied:Table
677 Disclosure of supplementary financial statement information [Abstract] Abstract blrx:DisclosureOfSupplementaryFinancialStatementInformationAbstract
678 Interest expense and exchange differences Concept (Monetary) For Period Debit blrx:InterestExpenseAndExchangeDifferences
679 Bank commissions Concept (Monetary) For Period Debit ifrs-full:FeeAndCommissionExpense
680 Financial expenses Concept (Monetary) For Period Debit ifrs-full:FinanceCosts
681 00000074 - Disclosure - AGALIMMUNE ACQUISITION (Details) Network

*

*

 http://biolinerx.com/role/AgalimmuneAcquisitionDetails
682 Disclosure of detailed information about business combination [table] Table

*

*

 ifrs-full:DisclosureOfBusinessCombinationsTable
683 Business combinations [Axis] Axis ifrs-full:BusinessCombinationsAxis
684 Entity's total for business combinations [member] Member ifrs-full:EntitysTotalForBusinessCombinationsMember
685 Agalimmune Ltd. [Member] Member blrx:AgalimmuneLtdMember
686 Disclosure of detailed information about business combination [line items] LineItems ifrs-full:DisclosureOfBusinessCombinationsLineItems
687 Initial consideration Concept (Monetary) As Of Credit ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
688 Cash consideration Concept (Monetary) As Of Credit ifrs-full:CashTransferred
689 Total costs associated with bringing assets Concept (Monetary) As Of Debit ifrs-full:ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDate
690 Total increase in intangibles Concept (Monetary) As Of Debit ifrs-full:CustomerrelatedIntangibleAssetsRecognisedAsOfAcquisitionDate
691 00000075 - Disclosure - AMENDMENT TO BL-8040 LICENSE AND LONG-TERM LOAN (Details) Network

*

*

 http://biolinerx.com/role/AmendmentToBl-8040LicenseAndLong-termLoanDetails
692 Disclosure of detailed information about business combination [table] Table

*

*

 ifrs-full:DisclosureOfBusinessCombinationsTable
693 Categories of related parties [Axis] Axis ifrs-full:CategoriesOfRelatedPartiesAxis
694 Entity's total for related parties [member] Member ifrs-full:EntitysTotalForRelatedPartiesMember
695 Biokine Therapeutics Ltd [Member] Member blrx:BiokineTherapeuticsLtdMember
696 Range [Axis] Axis ifrs-full:RangeAxis
697 Ranges [member] Member ifrs-full:RangesMember
698 Bottom of range [Member] Member ifrs-full:BottomOfRangeMember
699 Top of range [Member] Member ifrs-full:TopOfRangeMember
700 Borrowings by name [Axis] Axis ifrs-full:BorrowingsByNameAxis
701 Borrowings by name [member] Member ifrs-full:BorrowingsByNameMember
702 Loan from Kreos Capital [Member] Member blrx:KreosLoanMember
703 Disclosure of detailed information about business combination [line items] LineItems ifrs-full:DisclosureOfBusinessCombinationsLineItems
704 Percentage of Reduce payment owed on sublicense receipts Concept (Percent) For Period blrx:PercentageOfReducePaymentOwedOnSublicenseReceipts
705 Cash payment Concept (Monetary) As Of Credit ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
706 Issuance of ADS, value Concept (Monetary) For Period Debit blrx:IssuanceOfAdsValue
707 Amount of payment in futrue milestone Concept (Monetary) For Period Credit blrx:AmountOfPaymentInFutrueMilestone
708 Percetnage of additonal upfront sublicense Concept (Percent) For Period blrx:PercetnageOfAdditonalUpfrontSublicense
709 Borrowings Concept (Monetary) As Of Credit ifrs-full:Borrowings
710 Interest rate Concept (Percent) As Of ifrs-full:BorrowingsInterestRate
711 Number of warrant purchase Concept (Shares) As Of blrx:NumberOfWarrantPurchase
712 Exercise of price per ADS Concept (Share) As Of blrx:ExerciseOfPricePerAds
713 Fair value of warrant Concept (Monetary) As Of Credit ifrs-full:WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
714 Risk-free interest rate Concept (Percent) For Period ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
715 Average standard deviation Concept (Percent) For Period ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
716 Non-operating income Concept (Monetary) For Period Credit ifrs-full:OtherOperatingIncomeExpense
717 Issuance of stock Concept (Shares) As Of ifrs-full:NumberOfSharesIssued
718 00000076 - Disclosure - EVENT SUBSEQUENT TO THE BALANCE SHEET DATE (Details) Network

*

*

 http://biolinerx.com/role/EventSubsequentToBalanceSheetDateDetails
719 Statement Table [Table] Table

*

*

 blrx:IfrsStatementTable
720 Non-adjusting events after reporting period [axis] Axis ifrs-full:NonadjustingEventsAfterReportingPeriodAxis
721 Non-adjusting events after reporting period [member] Member ifrs-full:NonadjustingEventsMember
722 Public offering [Member] Member blrx:PublicOfferingMember
723 Statement Line Items [Line Items] LineItems blrx:IfrsStatementLineItems
724 Number of shares issued Concept (Shares) As Of ifrs-full:NumberOfSharesIssued
725 Number of warrant purchase Concept (Shares) As Of blrx:NumberOfWarrantPurchase
726 Exercise price Concept (Monetary) As Of ifrs-full:ExercisePriceOfOutstandingShareOptions
727 Expiry Concept (Text/String) For Period blrx:Expiry
728 Exercise of price per ADS Concept (Share) As Of blrx:ExerciseOfPricePerAds
729 Proceeds from shares issued Concept (Monetary) For Period Debit ifrs-full:ProceedsFromIssuingShares
730 Net proceeds from shares issued after deducting fees and expenses Concept (Monetary) For Period Debit blrx:NetProceedsFromIssuingShares

*

*